Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs
Regulatory exclusivity is a government-granted delay on generic drug approvals that often lasts longer than patents. It's a major reason why brand-name drugs stay expensive-even after patents expire.
Read More